New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 4, 2014
09:12 EDTJCP, INSY, VIPS, OXBT, SUNE, MDR, SNTA, SUTR, RSH, SSNLFOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Vipshop (VIPS), up 23%... Insys Therapeutics (INSY), up 21%. ALSO HIGHER: J.C. Penney (JCP), up 8% after S&P raised its outlook to stable from negative and affirmed its 'CCC+' corporate credit rating for the company.... Sutor Technology (SUTR), up 23% after subsidiary enters into supply contract with Samsung (SSNLF)... Oxygen Biotherapeutics (OXBT), up 31% after FDA lifts clinical hold on Oxycyte... SunEdison (SUNE), up 7.7% following upgrade at Morgan Stanley. DOWN AFTER EARNINGS: RadioShack (RSH), down 23.5%. ALSO LOWER: Synta Pharmaceuticals (SNTA), down 5.9% after CEO resigns... McDermott (MDR), down 8% after its fourth quarter earnings sharply missed estimates and the company withdrew prior guidance and suspended future guidance "for the foreseeable future."
News For JCP;RSH;SUTR;SNTA;MDR;SUNE;OXBT;VIPS;INSY;SSNLF From The Last 14 Days
Check below for free stories on JCP;RSH;SUTR;SNTA;MDR;SUNE;OXBT;VIPS;INSY;SSNLF the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
July 22, 2014
09:07 EDTSNTASynta Pharmaceuticals data positive, says JMP Securities
JMP Securities believes that early top-line data indicates Synta's ganetespib plus current standard of care, low-dose Ara-C provide clinical benefit in high-risk elderly patients with newly diagnosed AML and MDS. The firm says the results increase its confidence in a positive GALAXY-2 outcome in NSCLC and broad applicability of ganetespib across a variety of tumor types. It keeps an Outperform rating on the stock.
07:03 EDTSUNESunEdison signs PPA with Southern Nevada Water Authority
SunEdison announced that it has signed a 20-year power purchase agreement, or PPA, with the Southern Nevada Water Authority, or SNWA. The power purchase agreement enables SNWA to lock in a significant portion of its energy costs at a fixed rate, providing an effective hedge against future increases. As part of the agreement, SunEdison will develop, construct, own and operate a 14 megawatt AC solar photovoltaic power plant, located in Clark County, Nevada. Construction of the facility will begin in early 2015 with commercial operation slated for later that year.
06:21 EDTSSNLFWitsView: Acer surpasses Samsung in Chromebook shipments in Q2, DigiTimes says
Subscribe for More Information
06:17 EDTSSNLFGlobal notebook shipments to increase 4.3% in Q3, DigiTimes Research says
Subscribe for More Information
July 21, 2014
16:32 EDTSNTASynta Pharmaceuticals advances ganetespib into Phase 3 extension of AML LI-1
Synta Pharmaceuticals announced the advancement of ganetespib into the Phase 3 extension of the AML LI-1 trial. AML LI-1 is a multicenter, randomized Phase 2/3 clinical study evaluating several novel treatment regimens, including the combination of ganetespib with low dose cytarabine, in newly diagnosed elderly patients with acute myeloid leukemia or high-risk myelodysplastic syndrome who are not eligible for intensive chemotherapy. Ganetespib is a next-generation inhibitor of the chaperone protein Hsp90, which is critical for the activation and stability of numerous proteins that drive cancer growth and proliferation. Ganetespib has been studied in over 1000 patients to date. Advancement into the Phase 3 extension follows an interim analysis of results from 50 patients who received the ganetespib-cytarabine combination in the Phase 2 portion of the trial. The primary efficacy outcome in Phase 2 was rate of complete response. Per protocol, the Phase 3 extension will include an interim futility analysis and enroll approximately 200 patients in the ganetespib-cytarabine and the cytarabine alone arms, for a total of approximately 400 patients. The primary efficacy endpoint for the Phase 3 extension will include overall survival. The Company is currently in discussion with study investigators, and anticipates providing additional details, including the timing of study milestones, as they become formalized. The AML LI-1 trial is the first of three multicenter, randomized studies supported by the Leukemia & Lymphoma Research Fund and Cancer Research UK to include a ganetespib treatment arm. AML LI-1 is being conducted under the auspices of the UKs National Cancer Research Institute Haematological Oncology Study Group, with investigators in Denmark, France, New Zealand, and the UK, and under the sponsorship of Cardiff University, UK. The other two studies, to be initiated later this year, are the AML-18 trial, evaluating ganetespib with standard DA in patients over 60 years old who can tolerate intensive chemotherapy, and the AML-19 trial, evaluating ganetespib in combination with conventional chemotherapy in younger patients with AML.
08:12 EDTMDRMcDermott unit awarded contract from Walter Oil & Gas
Subscribe for More Information
07:20 EDTSSNLFSamsung China supplier stops production amid investigation, Reuters says
Subscribe for More Information
July 18, 2014
12:48 EDTSUNESolar stocks rise after successful IPO in space
Shares of solar energy companies are rising after a solar energy company's subsidiary surged on its first day of trading. WHAT'S NEW: The shares of SunEdison (SUNE) subsidiary TerraForm (TERP) are surging 36% in early afternoon trading. TerraForm Power opened at $33.26 and was trading near $34 per share at midday, after its initial public offering priced at $25 per share. TerraForm was formed to own and operate assets that generate clean power and the company plans to pay dividends. In a note to investors yesterday, Josh Baribeau, an analyst at Canaccord Genuity, wrote that TerraForm is a Yieldco. Subsidiaries of energy companies that own power plants and projects, Yieldcos typically trade on stock exchanges. Noting that TerraForm's IPO had priced at the high end of its expected range yesterday and was well oversubscribed, Baribeau wrote that this outcome reflects the strong demand for Yieldcos among investors. The Yieldcos provide investors with yield which is in high demand in today's low interest rate environment, the analyst stated. Additionally, as a result of the strong demand for Yieldcos' stocks, they provide their parent companies with "cheap and abundant capital," the analyst stated. SunEdison and TerraForm will grow their combined cash available for distributions at a faster rate than their target of 15% over the next three years, helping SunEdison's stock rise, the analyst stated. He kept a $30 price target and Buy rating on SunEdison. WHAT'S NOTABLE: A number of solar energy companies that own solar projects could form Yieldcos, research firm Trefis wrote in a Forbes column last month. Like Canaccord's Baribeau, Trefis believes that Yieldcos provide their parent companies with a cheap source of funding. Yieldcos also distribute most of their cash through dividends, Trefis stated. The firm named First Solar (FSLR) and SunPower (SPWR) as companies that could launch their own Yieldcos. PRICE ACTION: In early afternoon trading, Terraform jumped 36% to $34 and SunEdison was down 1% to $22.76. Meanwhile, First Solar rose 1.4% to $62.29, SunPower climbed 2.7% to $38.71, JinkoSolar gained 2.8% to $26.75, and Canadian Solar (CSIQ) advanced 3% to $28.71.
10:48 EDTINSYHigh option volume stocks
Subscribe for More Information
10:40 EDTJCPJ.C. Penney call active on renewed takeover chatter
Subscribe for More Information
10:38 EDTSUNETerraForm Power opens at $33.26, IPO priced at $25.00
Subscribe for More Information
10:33 EDTSUNETerraForm Power indicated to open at $33.70
Subscribe for More Information
10:28 EDTJCPRumor: J.C. Penney moves up on renewed takeover chatter
10:24 EDTSUNETerraForm Power indicated to open $33.05
Subscribe for More Information
10:03 EDTSUNETerraForm Power indicated to open $32.50 on 3M shares
TerraForm Power (TERP) is a subsidiary of SunEdison (SUNE).
10:00 EDTSUNETerraForm Power indicated to open $32.00
Subscribe for More Information
09:52 EDTSUNETerraForm Power indicated to open $31.50
Subscribe for More Information
06:41 EDTSUNETerraForm Power IPO priced at $25 per share
Subscribe for More Information
06:08 EDTSSNLFSamsung mobile executives return part of bonuses, Yonhap News reports
Subscribe for More Information
06:02 EDTSSNLFDRAMeXchange: Global DRAM module sales grew 32% in 2013, DigiTimes says
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use